SpyGlass Pharma, Inc. Common Stock (SGP)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Headquarters
- United States
- Employees
- 65
- Market Cap
- $760M
About SpyGlass Pharma, Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
SentiSense also tracks daily options readings for SpyGlass Pharma, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
SpyGlass Pharma, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.